Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong
· Delayed Price · Currency is HKD 41.74
+0.42 (1.02%)
At close: Apr 29, 2026
Sunshine Lake Pharma Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 23,799 | 26,274 | 8,412 | 8,351 | 5,720 | 5,368 | Upgrade
|
| Market Cap Growth | 169.92% | 212.32% | 0.74% | 46.00% | 6.56% | -30.92% | Upgrade
|
| Enterprise Value | 27,328 | 34,991 | 9,289 | 9,299 | 9,130 | 7,738 | Upgrade
|
| Last Close Price | 41.32 | 45.60 | 32.84 | 32.60 | 22.33 | 20.95 | Upgrade
|
| PE Ratio | 67.51 | 86.66 | 16.38 | 3.80 | 66.05 | - | Upgrade
|
| PS Ratio | 4.44 | 4.90 | 2.12 | 1.20 | 1.35 | 4.79 | Upgrade
|
| PB Ratio | 4.93 | 5.44 | 0.93 | 0.96 | 0.83 | 0.73 | Upgrade
|
| P/TBV Ratio | 6.02 | 6.65 | 1.32 | 1.41 | 1.71 | 1.19 | Upgrade
|
| P/FCF Ratio | - | - | - | 5.70 | 4.48 | - | Upgrade
|
| P/OCF Ratio | - | - | 88.41 | 4.53 | 2.98 | - | Upgrade
|
| EV/Sales Ratio | 5.10 | 6.53 | 2.34 | 1.34 | 2.16 | 6.90 | Upgrade
|
| EV/EBITDA Ratio | 22.85 | 29.26 | 8.29 | 2.66 | 11.68 | - | Upgrade
|
| EV/EBIT Ratio | 35.53 | 45.49 | 13.05 | 3.03 | 25.02 | - | Upgrade
|
| EV/FCF Ratio | - | - | - | 6.35 | 7.15 | - | Upgrade
|
| Debt / Equity Ratio | 1.08 | 1.08 | 0.26 | 0.33 | 0.63 | 0.53 | Upgrade
|
| Debt / EBITDA Ratio | 4.35 | 4.35 | 2.10 | 0.82 | 5.46 | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 1.96 | 3.38 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.73 | 0.73 | 0.10 | 0.12 | 0.43 | 0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.96 | 2.96 | 0.79 | 0.30 | 3.77 | -9.98 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -0.94 | 0.70 | 2.31 | -2.02 | Upgrade
|
| Asset Turnover | 0.39 | 0.39 | 0.30 | 0.51 | 0.33 | 0.09 | Upgrade
|
| Inventory Turnover | 1.58 | 1.58 | 1.76 | 3.62 | 3.02 | 1.31 | Upgrade
|
| Quick Ratio | 0.56 | 0.56 | 1.29 | 0.87 | 0.46 | 1.36 | Upgrade
|
| Current Ratio | 0.77 | 0.77 | 1.77 | 1.40 | 1.01 | 1.66 | Upgrade
|
| Return on Equity (ROE) | 4.20% | 4.20% | 5.87% | 26.50% | 0.81% | -10.57% | Upgrade
|
| Return on Assets (ROA) | 3.54% | 3.54% | 3.32% | 14.16% | 1.80% | -2.85% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.65% | 5.04% | 6.14% | 27.75% | 3.85% | -6.47% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.60% | 11.60% | 7.00% | 33.20% | 4.60% | -4.90% | Upgrade
|
| Earnings Yield | 1.27% | 1.15% | 6.11% | 26.29% | 1.51% | -13.44% | Upgrade
|
| FCF Yield | - | - | -11.12% | 17.54% | 22.33% | -23.30% | Upgrade
|
| Buyback Yield / Dilution | -114.82% | -114.82% | - | - | - | 20.42% | Upgrade
|
| Total Shareholder Return | -100.94% | -114.82% | - | - | - | 20.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.